KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Current Assets (2016 - 2025)

Historic Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $29.4 billion.

  • Bristol Myers Squibb's Current Assets fell 130.96% to $29.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $29.4 billion, marking a year-over-year decrease of 130.96%. This contributed to the annual value of $29.4 billion for FY2025, which is 130.96% down from last year.
  • Bristol Myers Squibb's Current Assets amounted to $29.4 billion in Q4 2025, which was down 130.96% from $35.6 billion recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Current Assets peaked at $35.6 billion during Q3 2025, and registered a low of $26.8 billion during Q3 2022.
  • In the last 5 years, Bristol Myers Squibb's Current Assets had a median value of $29.3 billion in 2021 and averaged $29.6 billion.
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 1800.55% in 2022, then surged by 2691.01% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Current Assets stood at $33.3 billion in 2021, then fell by 18.01% to $27.3 billion in 2022, then rose by 16.49% to $31.8 billion in 2023, then decreased by 6.26% to $29.8 billion in 2024, then decreased by 1.31% to $29.4 billion in 2025.
  • Its Current Assets was $29.4 billion in Q4 2025, compared to $35.6 billion in Q3 2025 and $33.2 billion in Q2 2025.